Patient Care and Medication Safety

2013

• April 18: APA and Physician Community Support Letter for H.R. 1427, the Truth in Health Marketing Act of 2013

2012

• October 10: Alcohol Misuse Screenings and Counseling Interventions
• August 21: Non-discrimination on the Basis of Disability in Air Travel
• July 9: APA Letter of Support to Rep. Tim Murphy (R-PA) on  Behavioral Health Information Technology Act of 2012
• May 22: Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs (Antipsychotic Previsions)
• April 6: APA Response to CMS's Analyses Regarding Intensive Behavioral Therapy for Obesity 
• April 3: MHLG Letter Regarding Use of Word "Lunatic" in Federal Law
• March 9: Use of Restraint and Seclusion in Psychiatric Residential Treatment Facilities Providing Psychiatric Services to Individuals Under Age 21

2011

• December 1: The Financial and Societal Costs of Medicating America’s Foster Children
• November 30: APA Comment on Senate Hearing, "Overprescribed: The Human and Taxpayers’ Costs of Antipsychotics in Nursing Homes"
• November 29: FDA Opioid Prescriber
• November 10: Letter to CMS Regarding the Clinical Laboratory Improvement Amendments (CLIA) Program and HIPAA Privacy Rule; Patients’ Access to Test Reports
• October 27: APA's Final Statement for the House Subcommittee on Human Resources on SSI and Children
• September 23: APA Comments on Metadata
• August 31: PCORI Comments
• August 17: Proposed Rules for Screening for Depression in Adults (CAG-00425N) and Screening and Behavioral Counseling Interventions in Primary Care to Reduce Alcohol Misuse (CAG-00427N)
• July 19: HIPAA Privacy Rule Accounting of Disclosures under the Health Information Technology for Economic and Clinical Health Act
• May 27: NIDA Youth Opioids comments
• May 6: APA Comments on Office of the National Coordinator for HIT 5 year Strategic Plan 5611
• January 1: Preparing for Drug Enforcement Agency Audits of DATA-Waived Prescribers